Skip to main content
Table of Contents
Print

What are the success rates of cannabis treatments for fibromyalgia? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Cannabis is increasingly being considered as a therapeutic option for fibromyalgia , but what do the cannabis success rates look like? While data is still emerging, early findings from surveys and clinical observations offer promising insight. 

As with many chronic conditions, responses vary by individual. However, general patterns from patient reports and observational studies indicate that many people do experience noticeable improvements in symptoms. This includes reduced pain, better sleep, and improved mood all of which contribute to overall quality of life. 

What the data shows about cannabis success rates 

Here’s a look at the reported cannabis success rates, based on available research and patient feedback: 

Pain and Symptom Relief 

Several surveys suggest that 50–70% of patients experience significant symptom improvement, often within weeks of starting cannabis treatment. 

Overall Relief Percentage 

The relief percentage varies, but studies often report that over half of fibromyalgia patients achieve moderate to high levels of relief with consistent cannabis use. 

Daily Function and Sleep 

Improved sleep and energy levels are commonly reported, which enhances daily functioning and lowers fatigue. 

Patient Success 

Long-term patient success is linked to finding the right dosage, strain, and delivery method, often in partnership with a knowledgeable medical professional. 

While not a cure, cannabis appears to offer substantial benefits for a significant portion of those with fibromyalgia. Tracking cannabis success rates helps inform treatment strategies and provides realistic expectations for those exploring this option. Consulting with a specialist remains key to achieving the best possible outcome. 

If you’re exploring cannabis treatment options for fibromyalgia, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Fibromyalgia. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories